Cargando…

Neoantigen Quantity and Quality in Relation to Pancreatic Cancer Survival

INTRODUCTION: Factors underlying antitumor immunity in pancreatic cancer (PC) are poorly understood. We hypothesized that not neoantigen quantity, but quality, is related to immune cell infiltration and survival. METHODOLOGY: We performed genomic and transcriptomic profiling of paired normal, tumor...

Descripción completa

Detalles Bibliográficos
Autores principales: Levink, Iris J. M., Brosens, Lodewijk A. A., Rensen, Sander S., Aberle, Merel R., Olde Damink, Steven S. W., Cahen, Djuna L., Buschow, Sonja I., Fuhler, Gwenny M., Peppelenbosch, Maikel P., Bruno, Marco J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864178/
https://www.ncbi.nlm.nih.gov/pubmed/35223878
http://dx.doi.org/10.3389/fmed.2021.751110
_version_ 1784655400477392896
author Levink, Iris J. M.
Brosens, Lodewijk A. A.
Rensen, Sander S.
Aberle, Merel R.
Olde Damink, Steven S. W.
Cahen, Djuna L.
Buschow, Sonja I.
Fuhler, Gwenny M.
Peppelenbosch, Maikel P.
Bruno, Marco J.
author_facet Levink, Iris J. M.
Brosens, Lodewijk A. A.
Rensen, Sander S.
Aberle, Merel R.
Olde Damink, Steven S. W.
Cahen, Djuna L.
Buschow, Sonja I.
Fuhler, Gwenny M.
Peppelenbosch, Maikel P.
Bruno, Marco J.
author_sort Levink, Iris J. M.
collection PubMed
description INTRODUCTION: Factors underlying antitumor immunity in pancreatic cancer (PC) are poorly understood. We hypothesized that not neoantigen quantity, but quality, is related to immune cell infiltration and survival. METHODOLOGY: We performed genomic and transcriptomic profiling of paired normal, tumor tissue of 13 patients with PC with distinct survival times. Additionally, neoantigens prediction and immunological profiling were performed. RESULTS: The proportion of neoantigens with a low similarity-to-self score was higher in short-term survivors (p < 0.0001), while mutational load and burden, similarity-to-known-pathogens, and immunogenicity of neoantigens were not associated with immune cell infiltration or survival. DISCUSSION: No tumor mutational load or neoantigen quantity, but low similarity-to-self score, was associated with immune cell infiltration and survival.
format Online
Article
Text
id pubmed-8864178
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88641782022-02-24 Neoantigen Quantity and Quality in Relation to Pancreatic Cancer Survival Levink, Iris J. M. Brosens, Lodewijk A. A. Rensen, Sander S. Aberle, Merel R. Olde Damink, Steven S. W. Cahen, Djuna L. Buschow, Sonja I. Fuhler, Gwenny M. Peppelenbosch, Maikel P. Bruno, Marco J. Front Med (Lausanne) Medicine INTRODUCTION: Factors underlying antitumor immunity in pancreatic cancer (PC) are poorly understood. We hypothesized that not neoantigen quantity, but quality, is related to immune cell infiltration and survival. METHODOLOGY: We performed genomic and transcriptomic profiling of paired normal, tumor tissue of 13 patients with PC with distinct survival times. Additionally, neoantigens prediction and immunological profiling were performed. RESULTS: The proportion of neoantigens with a low similarity-to-self score was higher in short-term survivors (p < 0.0001), while mutational load and burden, similarity-to-known-pathogens, and immunogenicity of neoantigens were not associated with immune cell infiltration or survival. DISCUSSION: No tumor mutational load or neoantigen quantity, but low similarity-to-self score, was associated with immune cell infiltration and survival. Frontiers Media S.A. 2022-02-09 /pmc/articles/PMC8864178/ /pubmed/35223878 http://dx.doi.org/10.3389/fmed.2021.751110 Text en Copyright © 2022 Levink, Brosens, Rensen, Aberle, Olde Damink, Cahen, Buschow, Fuhler, Peppelenbosch and Bruno. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Levink, Iris J. M.
Brosens, Lodewijk A. A.
Rensen, Sander S.
Aberle, Merel R.
Olde Damink, Steven S. W.
Cahen, Djuna L.
Buschow, Sonja I.
Fuhler, Gwenny M.
Peppelenbosch, Maikel P.
Bruno, Marco J.
Neoantigen Quantity and Quality in Relation to Pancreatic Cancer Survival
title Neoantigen Quantity and Quality in Relation to Pancreatic Cancer Survival
title_full Neoantigen Quantity and Quality in Relation to Pancreatic Cancer Survival
title_fullStr Neoantigen Quantity and Quality in Relation to Pancreatic Cancer Survival
title_full_unstemmed Neoantigen Quantity and Quality in Relation to Pancreatic Cancer Survival
title_short Neoantigen Quantity and Quality in Relation to Pancreatic Cancer Survival
title_sort neoantigen quantity and quality in relation to pancreatic cancer survival
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864178/
https://www.ncbi.nlm.nih.gov/pubmed/35223878
http://dx.doi.org/10.3389/fmed.2021.751110
work_keys_str_mv AT levinkirisjm neoantigenquantityandqualityinrelationtopancreaticcancersurvival
AT brosenslodewijkaa neoantigenquantityandqualityinrelationtopancreaticcancersurvival
AT rensensanders neoantigenquantityandqualityinrelationtopancreaticcancersurvival
AT aberlemerelr neoantigenquantityandqualityinrelationtopancreaticcancersurvival
AT oldedaminkstevensw neoantigenquantityandqualityinrelationtopancreaticcancersurvival
AT cahendjunal neoantigenquantityandqualityinrelationtopancreaticcancersurvival
AT buschowsonjai neoantigenquantityandqualityinrelationtopancreaticcancersurvival
AT fuhlergwennym neoantigenquantityandqualityinrelationtopancreaticcancersurvival
AT peppelenboschmaikelp neoantigenquantityandqualityinrelationtopancreaticcancersurvival
AT brunomarcoj neoantigenquantityandqualityinrelationtopancreaticcancersurvival